Please note that each item in this release references a different embargo time!
ROCKVILLE, Md. — Embargoed press materials are now available for the Association for Molecular Pathology 2025 Annual Meeting & Expo . Top clinicians, scientists and educators in the field will gather at the meeting Nov. 11–15 in Boston.
Reporters are invited to attend an exciting lineup of in-person scientific sessions or access press materials electronically. See registration requirements .
Featured research findings include:
Embargo lifts 2:45 p.m. Thursday, Nov. 13
Researchers at the University of Chicago adapted techniques originally used to study ancient DNA from archaeological specimens to recover genetic information from old medical samples.
Why it matters:
Key findings:
Embargo lifts 9:15 a.m. Friday, Nov. 14
Researchers at Indiana University Health have created a test that rapidly detects three serious U.S. fungal pathogens often misdiagnosed as other respiratory illnesses: Histoplasma, Blastomyces, and Coccidioides.
Researchers at Dartmouth Hitchcock Medical Center have developed a droplet digital PCR (ddPCR) test that may detect Lyme disease more accurately and earlier than traditional methods — potentially avoiding years-long diagnostic delays that can lead to severe complications.
Embargoes lift 9:15 a.m. Friday, Nov. 14
Embargo lifts 9:15 a.m. Saturday, Nov. 15
A Harvard/Brigham and Women’s Hospital team developed a targeted DNA test for X-linked dystonia-parkinsonism, a rare inherited movement disorder primarily affecting men of Filipino descent.
Two groups of researchers — one at Dartmouth–Hitchcock Medical Center and one at Queens University’s Kingston Health Sciences Centre and the University of Ottawa — found that optical genome mapping could help uncover causes of recurrent pregnancy loss.
The Association for Molecular Pathology was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP’s more than 3,100 members practice various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions and oncology. Our members are pathologists, clinical laboratory directors, basic and translational scientists, technologists and trainees who practice in a variety of settings, including academic and community medical centers, government and industry. Through the efforts of its Board of Directors, Committees, Working Groups and Members, AMP is the primary resource for expertise, education and collaboration in one of the fastest-growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high-quality, appropriate testing. For more information, visit www.amp.org .